December 03, 2020
Eywa Pharma is recalling 5451 bottles of 500-mg levetiracetam tablets after a 1000-mg tablet was found in a bottle, according to the December 2, 2020, US Food and Drug Administration (FDA) Enforcement Report.
The recall is for levetiracetam tablets, 500 mg, packaged in 120-count bottles (NDC 71930-063-52), from lot LEV5019021A (Exp. 10/21). The tablets were manufactured for Eywa Pharma by VKT Pharma Private Limited and distributed throughout the United States.
Eywa Pharma voluntarily initiated the recall November 10, 2020. On November 25, 2020, the FDA designated the recall Class II. Drugs affected by Class II recalls may cause temporary or medically reversible adverse health consequences if used. While remote, a possibility of serious harm also exists.
Levetiracetam is a prescription anticonvulsant used to treat adults and children with epilepsy.